+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 250 Pages
  • Global
From
From
From
Nephrology Drugs Market Report 2025 - Product Thumbnail Image

Nephrology Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Albumin Excipient Market Report 2025 - Product Thumbnail Image

Albumin Excipient Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Biobetters Market - Growth, Trends, and Forecast(2022 - 2027) - Product Thumbnail Image

Biobetters Market - Growth, Trends, and Forecast(2022 - 2027)

  • Report
  • January 2022
  • 115 Pages
  • Global
From
From
From
From
Global Non-Cancerous Blood Disease Market Analysis 2021-2031 - Product Thumbnail Image

Global Non-Cancerous Blood Disease Market Analysis 2021-2031

  • Report
  • April 2022
  • 307 Pages
  • Global
From
Loading Indicator